2022
DOI: 10.1016/j.jsps.2022.03.011
|View full text |Cite
|
Sign up to set email alerts
|

Determination of anticancer potential of a novel pharmacologically active thiosemicarbazone derivative against colorectal cancer cell lines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
7
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 56 publications
0
7
0
Order By: Relevance
“…[28,30,31] TSCs can be functionalized with diverse bioactive or pharmacophoric groups and have been amply studied in medicinal chemistry [31,32] including clinical trials for multiple cancers (NCT02595879, NCT02688101, and NCT02433626). [19,33] Studies have shown that the anti-tumor activity of the thiosemicarbazones is due to their ability to act by multiple mechanisms of action, [34][35][36][37][38][39][40] such as inhibition of DNA synthesis, inhibition of cell proliferation, cell cycle, angiogenesis and metastasis, and modulation of signaling pathways. [39,40] These effects are produced by inhibition of targets such cysteine proteases, [33,37] ribonucleotide reductase, [36] cysteine proteases, [33,37] and/or the generation of reactive oxygen species (ROS).…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations
“…[28,30,31] TSCs can be functionalized with diverse bioactive or pharmacophoric groups and have been amply studied in medicinal chemistry [31,32] including clinical trials for multiple cancers (NCT02595879, NCT02688101, and NCT02433626). [19,33] Studies have shown that the anti-tumor activity of the thiosemicarbazones is due to their ability to act by multiple mechanisms of action, [34][35][36][37][38][39][40] such as inhibition of DNA synthesis, inhibition of cell proliferation, cell cycle, angiogenesis and metastasis, and modulation of signaling pathways. [39,40] These effects are produced by inhibition of targets such cysteine proteases, [33,37] ribonucleotide reductase, [36] cysteine proteases, [33,37] and/or the generation of reactive oxygen species (ROS).…”
Section: Introductionmentioning
confidence: 99%
“…[19,33] Studies have shown that the anti-tumor activity of the thiosemicarbazones is due to their ability to act by multiple mechanisms of action, [34][35][36][37][38][39][40] such as inhibition of DNA synthesis, inhibition of cell proliferation, cell cycle, angiogenesis and metastasis, and modulation of signaling pathways. [39,40] These effects are produced by inhibition of targets such cysteine proteases, [33,37] ribonucleotide reductase, [36] cysteine proteases, [33,37] and/or the generation of reactive oxygen species (ROS). [38] Thiosemicarbazones contain a soft sulfur donor atom able to easily coordinate to gold(I) centers.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…In this context, cell cycle arrest is one of the main mechanisms that are involved in the development of anticancer compounds. The literature data highlighted that antiproliferative TSCs could affect cell cycle progression: some of them can induce G1/S [ 37 , 38 ] or G2/M [ 39 , 40 ] cell cycle block, while other compounds do not cause cell cycle arrest.…”
Section: Introductionmentioning
confidence: 99%